Diet-Induced Inflammation Positively Tied to Marker of Heart Failure
By Lori Solomon HealthDay Reporter
THURSDAY, June 6, 2024 -- There is a positive correlation between diet-induced inflammation and a heart failure biomarker, according to a study published online June 5 in PLOS ONE.
Teng-Chi Ma, from the First Affiliated Hospital of Xi'an Jiaotong University in China, and colleagues used data from the National Health and Nutrition Examination Survey (1999 to 2004; 10,766 individuals) to investigate the association between diet-induced inflammation (measured by the Dietary Inflammatory Index [DII]) and heart failure (measured by N-terminal pro B-type natriuretic peptide [NT-proBNP]).
The researchers found that in individuals without heart failure, a unit increase in the DII was significantly associated with an increase in NT-proBNP levels when adjusting for demographic factors (8.57 pg/mL) and with further adjustments for health variables (5.54 pg/mL). For individuals with a history of heart failure, there was a trend toward higher NT-proBNP levels in the second and third DII quartile versus the lowest quartile (717.06 pg/mL and 855.49 pg/mL, respectively). There were also significant interactions by age (younger than 50 years: β = 3.63; 50 to 75 years: β = 18.4; 75 years and older: β = 56.09), gender (men: β = 17.82; women: β = 7.43), hypertension (β = 25.73), and diabetes (β = 38.94).
“This study identified a positive correlation between the DII and NT-proBNP levels, suggesting a robust link between pro-inflammatory diets and increased heart failure biomarkers, with implications for dietary modifications in cardiovascular risk management,” conclude the authors.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure
WEDNESDAY, June 26, 2024 -- For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women...
Triglyceride-Glucose Index Independently Linked to All-Cause Mortality
FRIDAY, June 21, 2024 -- The triglyceride-glucose (TyG) index is independently associated with all-cause mortality among patients with heart failure and chronic kidney disease...
Midlife Inflammation Tied to Slowing of Gait Speed in Later Life
FRIDAY, June 14, 2024 -- Inflammation in midlife may contribute to clinically meaningful late-life slowing of gait speed, according to a study published online June 12 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.